Co-Authors
This is a "connection" page, showing publications co-authored by Anastasia Kotanidou and Anastasia Antoniadou.
Connection Strength
0.232
-
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021 Apr 11; 9(4).
Score: 0.059
-
Coronavirus disease 2019 pandemic in Greece, February 26 - May 3, 2020: The first wave. Travel Med Infect Dis. 2021 May-Jun; 41:102051.
Score: 0.059
-
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19. PLoS One. 2020; 15(12):e0243025.
Score: 0.057
-
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study. Microorganisms. 2020 Nov 28; 8(12).
Score: 0.057